The U.S. Pharmacogenomics Market report focuses on the varying dynamics of the pharmacogenomics market. This report covers the Pharmacogenomics services, Gene-based Diagnostics, and Orphan Drugs segments. This report provides an in-depth analysis of the revenue sales forecasts for the market, drivers and restraints that affect the current and future markets, industry challenges and strategies, competitive, pricing and demand analysis and market and technology trends. The base year for this report is 2000.
Market Overview
- Pharmacogenomics and Polymorphisms
- The Advantages of Pharmacogenomics
- Market for Pharmacogenomics
Analysis by Major Segments
- Overview
- Service Market of Pharmacogenomics
- Diagnostics
- Orphan Drugs
- Overall Trends
- Competitive Analysis
- Technologies
Research and Scope
Methodology and Definitions
- Objectives and Validation
- Structure and Segmentation
- Forecast Period - Milestones
Total Market Analysis
- Research Methodology
- List of Definitions
- List of Acronyms
Conclusion
- Market Overview
- Market Challenges
- Market Drivers
- Market Restraints
- Market Forecast
Market Engineering Awards
- Recommendations
- Concluding Remarks
Service Market
Microarrays Market
Bioinformatics Market
Present Status of Diagnostics in Pharmacogenomics
Future Status for Diagnostics in Pharmacogenomics
Background
The Present Market for Orphan Drugs
The Future for Orphan Drugs
Speak directly with our analytics experts for tailored recommendations.
Recent related industry research
17 Sep 2026 | Asia Pacific | Frost Radar
Frost Radar™: Facility Management in Malaysia, 2026
Malaysia's facility management (FM) market is transitioning from labor-intensive, compliance-driven service delivery to technology-enabled, outcome-oriented, and sustainability-integrated operating models. Competitive differentiation increasingly depends on providers’ ability to combine integrated F...
17 Sep 2026 | Global | Market Research
Growth Opportunities in the Western Europe Consumer eSIM Market, 2026–2029
The consumer eSIM market in Western Europe is growing steadily, supported by the rising availability of eSIM-capable devices, particularly smartphones, and expanding travel-related use cases. However, commercialization has yet to translate into mass adoption. Despite Apple’s global launch of an eSIM...
17 Sep 2026 | Asia Pacific | Frost Radar
Frost Radar™: ASEAN Warehouse Automation System Providers, 2026
Warehouse automation has moved from a discretionary capital project to a core operating capability. ASEAN operators are redesigning fulfillment networks around smaller orders, shorter delivery windows, broader stock keeping unit (SKU) ranges, and sharper demand volatility. Manual operations remain v...
16 Sep 2026 | North America | Customer Research
US Automotive Technicians’ Choice Survey, 2025
The 2025 US Automotive Technicians’ Choice study is an insightful voice-of-customer survey that highlights the tool preferences of automotive aftermarket service technicians. The survey of 400 automotive technicians across the United States used a combination of computer-assisted telephone and compu...
16 Sep 2026 | Global | Market Research
Apple Performance Tracker, Q1 2026
This Frost & Sullivan tracker provides metrics on Apple's quarterly performance (for both unit sales and revenues) for iPads, iPhones, Macs, and other products, such as iPods, Apple TVs, Beats Electronics, and Apple-branded and third-party accessories. It includes historical quarterly data for all t...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Industries | Healthcare |
| WIP Number | 7965-01-00-00-00 |
| Is Prebook | No |
U.S. Pharmacogenomics Markets
$3,950.00
Special Price $2,962.50 save 25 %